| Ytd | -16.92% | |
| 1y | -4.42% |
| Open | 2.12 | Prev Close | 2.15 | Low | 2.12 | High | 2.19 | Mkt Cap | 23.18M |
| Vol | 6.84K | Avg Vol | 38.64K | EPS | -4.61 | P/E | N/A | Forward P/E | 3.57 |
| Beta | -1.40 | Short Ratio | 10.45 | Inst. Own | 34.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 2.29 | 200-d Avg | 2.37 | 1yr Est | 8.00 |
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001385818/000143774926021707/aytu20260624c_8k.htm
Ascendiant Capital analyst Edward Woo maintains Aytu BioPharma (NASDAQ:AYTU) with a Buy and raise